Association of human leukocyte antigen-A11 with resistance and B40 and DR2 with susceptibility to HIV-1 infection in South India [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 4, 2006, Pages 497-499

  Selvaraj, Paramasivam ^a   Swaminathan, Soumya ^a   Alagarasu, Kalichamy ^a   Raghavan, Sampathkumar ^a   Narendran, Gopalan ^a   Narayanan, Paramjir ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A1 ANTIGEN; HLA B ANTIGEN; HLA B40 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; DISEASE PREDISPOSITION; FEMALE; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; INDIA; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; INDIA; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 33750963327     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000233312.36226.76     Document Type: Letter

References (11)

1. Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet. 2001;2:373-400.
2. Al Jabri AA. HLA and in vitro susceptibility to HIV infection. Mol Immunol. 2002;38:959-967.
3. Sriwanthana B, Hodge T, Mastro TD, et al. HIV specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 Δ32-negative female sexworkers in Chiang Rai, Northern Thailand. AIDS Res Hum Retroviruses. 2001;17:719-734.
4. Allen TM, Yu XG, Kalife ET, et al. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T- lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol. 2005;79:12952-12960.
5. Sidney J, Grey HM, Southwood S, et al. Definition of HLA-A3 like supermotif demonstrates the overlapping peptide-binding repertoire of common HLA molecules. Hum Immunol. 1996;45:79-93.
6. Li L, Bouvier M. Structure of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveals presence of a middle, secondary anchor residue. J Immunol. 2004;172:6175-6184.
7. Shankarkumar U, Thakar M, Mehendale S, et al. Association of HLA B*3520 and B*1801 and Cw*1507 with HIV-1 infection in Maharastra, India. J Acquir Immune Defic Syndr. 2003;34:113-114.
8. Nelson WG, Kaslow R, Mann DL. Frequency of HLA allele specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad Sci USA. 1997;94:9802-9807.
9. Bothamley GH. Differences between HLA-B44 and HLA-B60 in patients with smear-positive pulmonary tuberculosis and exposed controls. J Infect Dis. 1999;179:1051-1052.
10. Fabio G, Marchini M, Smeraldi RS, et al. Possible association of HLA-DR2 phenotype and detectable human immunodeficiency virus (HIV) p24 antigen in HIV-positive patients. J Infect Dis. 1993;167:499-500.
11. Selvaraj P, Uma H, Reetha AM, et al. HLA antigen profile in pulmonary tuberculosis patients and their spouses. Indian J Med Res. 1998;107:208-217.